Business Description
Enwei Pharmaceutical Co Ltd
ISIN : CNE100005LC7
Share Class Description:
SZSE:301331: Class ACompare
Compare
Traded in other countries / regions
301331.China IPO Date
2022-09-21Description
Enwei Pharmaceutical Co Ltd is engaged in the research and development, production and sales of proprietary Chinese medicines and chemical medicines.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.45 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | 4.02 | |||||
| Interest Coverage | 27.41 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.42 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.5 | |||||
| 3-Year EBITDA Growth Rate | -15.4 | |||||
| 3-Year EPS without NRI Growth Rate | -19.3 | |||||
| 3-Year Book Growth Rate | 12.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.53 | |||||
| 9-Day RSI | 33.82 | |||||
| 14-Day RSI | 38.82 | |||||
| 6-1 Month Momentum % | 2.01 | |||||
| 12-1 Month Momentum % | -13.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.86 | |||||
| Quick Ratio | 4.25 | |||||
| Cash Ratio | 2.78 | |||||
| Days Inventory | 113.53 | |||||
| Days Sales Outstanding | 48.36 | |||||
| Days Payable | 35.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.37 | |||||
| Dividend Payout Ratio | 2.3 | |||||
| Forward Dividend Yield % | 3.37 | |||||
| 5-Year Yield-on-Cost % | 3.39 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 3.25 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.52 | |||||
| Operating Margin % | 5.3 | |||||
| Net Margin % | 4.56 | |||||
| FCF Margin % | -7.65 | |||||
| ROE % | 3.32 | |||||
| ROA % | 2.56 | |||||
| ROIC % | 4.73 | |||||
| ROC (Joel Greenblatt) % | 18.25 | |||||
| ROCE % | 4.25 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 70.94 | |||||
| PE Ratio without NRI | 69.31 | |||||
| PS Ratio | 3.19 | |||||
| PB Ratio | 2.43 | |||||
| Price-to-Tangible-Book | 3.17 | |||||
| Price-to-Operating-Cash-Flow | 23.66 | |||||
| EV-to-EBIT | 42.8 | |||||
| EV-to-EBITDA | 42.8 | |||||
| EV-to-Revenue | 2.77 | |||||
| EV-to-FCF | -38.68 | |||||
| Price-to-Graham-Number | 3.12 | |||||
| Price-to-Net-Current-Asset-Value | 5.35 | |||||
| Price-to-Net-Cash | 26.22 | |||||
| Earnings Yield (Greenblatt) % | 2.34 | |||||
| FCF Yield % | -2.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enwei Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 775.648 | ||
| EPS (TTM) (Â¥) | 0.34 | ||
| Beta | 0 | ||
| Volatility % | 42.61 | ||
| 14-Day RSI | 38.82 | ||
| 14-Day ATR (Â¥) | 1.020508 | ||
| 20-Day SMA (Â¥) | 25.25 | ||
| 12-1 Month Momentum % | -13.84 | ||
| 52-Week Range (Â¥) | 18.885135 - 32.5 | ||
| Shares Outstanding (Mil) | 102.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enwei Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enwei Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enwei Pharmaceutical Co Ltd Frequently Asked Questions
What is Enwei Pharmaceutical Co Ltd(SZSE:301331)'s stock price today?
The current price of SZSE:301331 is ¥24.12. The 52 week high of SZSE:301331 is ¥32.50 and 52 week low is ¥18.89.
When is next earnings date of Enwei Pharmaceutical Co Ltd(SZSE:301331)?
The next earnings date of Enwei Pharmaceutical Co Ltd(SZSE:301331) is .
Does Enwei Pharmaceutical Co Ltd(SZSE:301331) pay dividends? If so, how much?
The Dividend Yield %  of Enwei Pharmaceutical Co Ltd(SZSE:301331) is 3.37% (As of Today), Highest Dividend Payout Ratio of Enwei Pharmaceutical Co Ltd(SZSE:301331) was 2.3. The lowest was 1.53. And the median was 1.53. The  Forward Dividend Yield % of Enwei Pharmaceutical Co Ltd(SZSE:301331) is 3.37%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers